Plus   Neg

Bank Of Hawaii Q1 Profit Tops Estimates - Quick Facts

Bank of Hawaii Corp. (BOH) reported earnings per share of $0.87 for the first quarter of 2020, compared to $1.43, last year. On average, five analysts polled by Thomson Reuters expected the company to report profit per share of $0.73, for the quarter. Analysts' estimates typically exclude special items.

Net interest income, on a taxable-equivalent basis, for the first quarter of 2020 was $126.3 million, up $0.5 million from $125.8 million, prior year. Noninterest income was $46.1 million, an increase of $2.4 million compared with $43.7 million. Analysts expected revenue of $166.76 million for the quarter.

The company's Board declared a quarterly cash dividend of $0.67 per share on the company's outstanding shares. The dividend will be payable on June 12, 2020 to shareholders of record at the close of business on May 29, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
Follow RTT